Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Niko Resources Ltd. stock logo
NKO
Niko Resources
C$0.02
C$0.01
C$0.12
C$1.88MN/A466,121 shs3.98 million shs
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.20
+1.7%
$1.35
$1.09
$3.55
$86.20M0.88338,276 shs272,095 shs
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
$0.99
$0.10
$5.90
$2.90M1.581.81 million shs178.35 million shs
Synovus Financial Corp. stock logo
SNV
Synovus Financial
$36.63
+2.7%
$37.91
$24.40
$40.92
$5.22B1.41.48 million shs1.82 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Niko Resources Ltd. stock logo
NKO
Niko Resources
0.00%0.00%0.00%0.00%0.00%
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
+1.69%+3.90%-5.51%-18.37%-51.42%
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
0.00%0.00%0.00%0.00%-88.01%
Synovus Financial Corp. stock logo
SNV
Synovus Financial
+2.66%-0.03%-5.03%-5.23%+19.08%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Niko Resources Ltd. stock logo
NKO
Niko Resources
N/AN/AN/AN/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
2.4769 of 5 stars
3.50.00.00.00.60.03.1
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Synovus Financial Corp. stock logo
SNV
Synovus Financial
4.5708 of 5 stars
3.32.03.32.61.02.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Niko Resources Ltd. stock logo
NKO
Niko Resources
N/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
3.00
Buy$10.00733.33% Upside
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
N/AN/AN/AN/A
Synovus Financial Corp. stock logo
SNV
Synovus Financial
2.59
Moderate Buy$41.3812.95% Upside

Current Analyst Ratings

Latest SNV, NKO, PLX, and SFT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$37.00 ➝ $37.00
4/22/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$45.00 ➝ $39.00
4/19/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$44.00 ➝ $41.00
4/19/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$46.00 ➝ $42.00
4/19/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$45.00 ➝ $43.00
4/19/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$42.00 ➝ $39.00
4/19/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$46.00 ➝ $41.00
4/19/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$50.00 ➝ $48.00
4/19/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$42.00 ➝ $40.00
4/19/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$46.00 ➝ $38.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Niko Resources Ltd. stock logo
NKO
Niko Resources
C$13.23M0.00N/A0.37C($4.06) per share0.00
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$65.49M1.34$0.14 per share8.65$0.47 per share2.55
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
$328.81M0.00N/AN/A($3.47) per share0.00
Synovus Financial Corp. stock logo
SNV
Synovus Financial
$3.45B1.55$5.15 per share7.11$30.76 per share1.19

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Niko Resources Ltd. stock logo
NKO
Niko Resources
N/A-C$0.86N/AN/AN/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$8.31M$0.0524.001.48N/A12.69%29.73%10.17%5/2/2024 (Estimated)
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
-$172.04M-$12.31N/AN/AN/A-41.12%N/A-90.54%N/A
Synovus Financial Corp. stock logo
SNV
Synovus Financial
$543.71M$2.9212.548.344.0913.29%12.93%0.94%7/17/2024 (Estimated)

Latest SNV, NKO, PLX, and SFT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/18/2024Q1 2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
$0.99$0.79-$0.20$0.80$547.62 million$537.73 million    
3/14/2024Q4 2023
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
-$0.03-$0.07-$0.04-$0.07$8.15 million$10.49 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Niko Resources Ltd. stock logo
NKO
Niko Resources
N/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
N/AN/AN/AN/AN/A
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
N/AN/AN/AN/AN/A
Synovus Financial Corp. stock logo
SNV
Synovus Financial
$1.524.15%+4.81%52.05%2 Years

Latest SNV, NKO, PLX, and SFT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/4/2024
Synovus Financial Corp. stock logo
SNV
Synovus Financial
Quarterly$0.383.8%3/20/20243/21/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Niko Resources Ltd. stock logo
NKO
Niko Resources
N/A
0.01
0.01
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
N/A
1.54
1.12
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
N/A
1.33
0.92
Synovus Financial Corp. stock logo
SNV
Synovus Financial
0.45
0.89
0.89

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Niko Resources Ltd. stock logo
NKO
Niko Resources
N/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
16.53%
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
11.34%
Synovus Financial Corp. stock logo
SNV
Synovus Financial
83.85%

Insider Ownership

CompanyInsider Ownership
Niko Resources Ltd. stock logo
NKO
Niko Resources
N/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
4.97%
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
11.40%
Synovus Financial Corp. stock logo
SNV
Synovus Financial
0.81%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Niko Resources Ltd. stock logo
NKO
Niko Resources
N/A94.05 millionN/ANot Optionable
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
20873.05 million69.42 millionOptionable
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
46417.00 million15.06 millionOptionable
Synovus Financial Corp. stock logo
SNV
Synovus Financial
4,879146.42 million145.23 millionOptionable

SNV, NKO, PLX, and SFT Headlines

SourceHeadline
Synovus Financial Corp. (NYSE:SNV) to Post Q2 2024 Earnings of $0.95 Per Share, DA Davidson ForecastsSynovus Financial Corp. (NYSE:SNV) to Post Q2 2024 Earnings of $0.95 Per Share, DA Davidson Forecasts
americanbankingnews.com - April 24 at 2:36 AM
Synovus Financials (SNV) Equal Weight Rating Reaffirmed at Morgan StanleySynovus Financial's (SNV) Equal Weight Rating Reaffirmed at Morgan Stanley
americanbankingnews.com - April 23 at 4:32 AM
Synovus Financial (NYSE:SNV) Given New $39.00 Price Target at Truist FinancialSynovus Financial (NYSE:SNV) Given New $39.00 Price Target at Truist Financial
americanbankingnews.com - April 23 at 4:32 AM
Synovus Financial (NYSE:SNV) Receives "Equal Weight" Rating from Morgan StanleySynovus Financial (NYSE:SNV) Receives "Equal Weight" Rating from Morgan Stanley
marketbeat.com - April 22 at 2:31 PM
Truist Financial Trims Synovus Financial (NYSE:SNV) Target Price to $39.00Truist Financial Trims Synovus Financial (NYSE:SNV) Target Price to $39.00
marketbeat.com - April 22 at 1:31 PM
JPMorgan Chase & Co. Cuts Synovus Financial (NYSE:SNV) Price Target to $48.00JPMorgan Chase & Co. Cuts Synovus Financial (NYSE:SNV) Price Target to $48.00
americanbankingnews.com - April 22 at 4:00 AM
The Goldman Sachs Group Lowers Synovus Financial (NYSE:SNV) Price Target to $41.00The Goldman Sachs Group Lowers Synovus Financial (NYSE:SNV) Price Target to $41.00
americanbankingnews.com - April 21 at 5:56 AM
Synovus Financial (NYSE:SNV) Price Target Cut to $48.00Synovus Financial (NYSE:SNV) Price Target Cut to $48.00
americanbankingnews.com - April 21 at 5:56 AM
Synovus Financial (NYSE:SNV) Price Target Cut to $43.00Synovus Financial (NYSE:SNV) Price Target Cut to $43.00
americanbankingnews.com - April 21 at 5:56 AM
Synovus Financial (NYSE:SNV) PT Lowered to $42.00Synovus Financial (NYSE:SNV) PT Lowered to $42.00
americanbankingnews.com - April 21 at 5:56 AM
Synovus Financial (NYSE:SNV) PT Lowered to $39.00Synovus Financial (NYSE:SNV) PT Lowered to $39.00
americanbankingnews.com - April 21 at 5:56 AM
Synovus Financial (NYSE:SNV) Price Target Cut to $41.00Synovus Financial (NYSE:SNV) Price Target Cut to $41.00
americanbankingnews.com - April 21 at 5:56 AM
Louisiana State Employees Retirement System Takes Position in Synovus Financial Corp. (NYSE:SNV)Louisiana State Employees Retirement System Takes Position in Synovus Financial Corp. (NYSE:SNV)
marketbeat.com - April 21 at 5:08 AM
Wells Fargo & Company Lowers Synovus Financial (NYSE:SNV) Price Target to $40.00Wells Fargo & Company Lowers Synovus Financial (NYSE:SNV) Price Target to $40.00
americanbankingnews.com - April 21 at 4:28 AM
Synovus Financial (NYSE:SNV) Stock Rating Reaffirmed by Keefe, Bruyette & WoodsSynovus Financial (NYSE:SNV) Stock Rating Reaffirmed by Keefe, Bruyette & Woods
americanbankingnews.com - April 21 at 4:28 AM
Bank of America Lowers Synovus Financial (NYSE:SNV) Price Target to $40.00Bank of America Lowers Synovus Financial (NYSE:SNV) Price Target to $40.00
americanbankingnews.com - April 21 at 4:28 AM
Mirae Asset Global Investments Co. Ltd. Increases Stock Holdings in Synovus Financial Corp. (NYSE:SNV)Mirae Asset Global Investments Co. Ltd. Increases Stock Holdings in Synovus Financial Corp. (NYSE:SNV)
marketbeat.com - April 20 at 4:54 AM
Synovus Financial (NYSE:SNV) Stock Rating Lowered by Raymond JamesSynovus Financial (NYSE:SNV) Stock Rating Lowered by Raymond James
americanbankingnews.com - April 20 at 3:40 AM
Synovus Financial (NYSE:SNV) Price Target Cut to $42.00Synovus Financial (NYSE:SNV) Price Target Cut to $42.00
marketbeat.com - April 19 at 2:27 PM
Knights of Columbus Asset Advisors LLC Makes New Investment in Synovus Financial Corp. (NYSE:SNV)Knights of Columbus Asset Advisors LLC Makes New Investment in Synovus Financial Corp. (NYSE:SNV)
marketbeat.com - April 19 at 1:28 PM
Optimistic Synovus Outlook: Capital Flexibility and Valuation Discount Justify Buy RatingOptimistic Synovus Outlook: Capital Flexibility and Valuation Discount Justify Buy Rating
markets.businessinsider.com - April 19 at 12:32 PM
Barclays Reaffirms Their Hold Rating on Synovus (SNV)Barclays Reaffirms Their Hold Rating on Synovus (SNV)
markets.businessinsider.com - April 19 at 12:32 PM
Synovus Financial Corp. (NYSE:SNV) Q1 2024 Earnings Call TranscriptSynovus Financial Corp. (NYSE:SNV) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 19 at 12:32 PM
Keefe, Bruyette & Woods Downgrades Synovus Financial (NYSE:SNV) to Market PerformKeefe, Bruyette & Woods Downgrades Synovus Financial (NYSE:SNV) to Market Perform
marketbeat.com - April 19 at 8:25 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Niko Resources logo

Niko Resources

TSE:NKO
Niko Resources Ltd. engages in the exploration, development, and production of oil and natural gas in India and Bangladesh. It primarily holds interests in the D6 Block consisting of Dhirubhai 1 and 3 Fields, MA Field, R cluster development project, satellite cluster development project, and MJ field development project located off the coastline of Andhra Pradesh, India; and the Block 9 in the central area of Bangladesh. The company was founded in 1987 and is headquartered in Calgary, Canada.
Protalix BioTherapeutics logo

Protalix BioTherapeutics

NYSE:PLX
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.
Shift Technologies logo

Shift Technologies

NASDAQ:SFT
Shift Technologies, Inc., together with its subsidiaries, provides an ecommerce platform for buying and selling used cars in the United States. The company operates in two segments, Retail and Wholesale. It engages in the retail sale of used vehicles through its platform; and provides financing and vehicle protection products. The company also provides value-added products, such as vehicle service contracts, guaranteed asset protection waiver coverage, wheel and tire coverage, prepaid maintenance plans, and appearance protection plans. In addition, it is involved in the sale of used vehicles through wholesale auctions or directly to a wholesaler. The company was founded in 2013 and is headquartered in San Francisco, California.
Synovus Financial logo

Synovus Financial

NYSE:SNV
Synovus Financial Corp. operates as the bank holding company for Synovus Bank that provides commercial and consumer banking products and services. It operates through four segments: Community Banking, Wholesale Banking, Consumer Banking, and Financial Management Services. The company's commercial banking services include treasury and asset management, capital market, and institutional trust services, as well as commercial, financial, and real estate lending services. Its consumer banking services comprise accepting customary types of demand and savings deposits accounts; mortgage, installment, and other consumer loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; internet-based banking services; and bank credit and debit card services, including Visa and MasterCard services. The company also offers various other financial services, including portfolio management for fixed-income securities, investment banking, execution of securities transactions as a broker/dealer, trust management, and financial planning services, as well as provides individual investment advice on equity and other securities. The company was founded in 1888 and is headquartered in Columbus, Georgia.